focus -WSS

focus

author：focus 2025-09-29 21:28:58 - browse：4779

Alex Hogan/STAT

The J.P. Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

This year’s iteration, starting Monday in San Francisco, finds the biotech industry, in particular, in a curious spot. After a volatile 2023 that saw biotech stocks hit five-year lows in the fall, the sector had a bull run in the final weeks of the year, spurred by some high-dollar merger agreements and a prevailing sense that the macroeconomic winds were finally shifting in biotech’s direction.

Meanwhile, companies selling digital health services like telemedicine, health plans for virtual care, and AI tools for payers face a crucial year as they scramble to make good on profitability projections. Those companies, along with the country’s most powerful health systems, are seriously exploring AI, even ChatGPT, to help them meet financial milestones.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： STAT Executive Editor Rick Berke on STAT's 8th birthday

explore

WSS

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

The new shift in health care is toward less care

Cell therapy fails to slow type 1 diabetes, but safety is established

Key Senate committee drafts bipartisan bill to stem drug shortages

Cue Health's Covid

Medicare will require more price transparency from hospitals

hotspot

focus

hotspot

Peter Hotez and the public health issue of online harassment

Melinda French Gates resigns from Gates Foundation

New air purifier tech could be key to improving indoor air quality

Exact Sciences stock tumbles despite strong cancer detection sales

Trump demands the U.S. pay no more for drugs than other countries … again

Dogs on Prozac: What pet anti

The cancer drug shortage isn’t new — and neither are the solutions

STAT Executive Editor Rick Berke on STAT's 8th birthday

Cancer drug shortages should be causing more outrage

Medical bills so high, Medicare adding extra digits to claim forms

hotspot

Excited delirium, Elijah McClain, and emergency physicians

Diversity in clinical trials starts with building trust, experts say

Abortion clinic in Cancun will cater to Americans

More tobacco lobbyists active in statehouses

After traumatic brain injury, life support decisions can use more time

Why does health care cost so much? A reading guide

hotspot

focus

explore

hotspot